Latest News

PHARMAC widens access to funded treatments for multiple sclerosis

February 12, 2021 | Advocacy, Life with MS, Treatments

Media Release – 12 February 2021 – Released by PHARMAC PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their […]


Media Release – PHARMAC widens access to funded treatments for multiple sclerosis

February 12, 2021 | Advocacy, Life with MS, Treatments

(Pharmac Media Release – 12 February 2021) PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, […]


Making disability rights real in a pandemic

February 1, 2021 | Advocacy, Covid-19

The COVID-19 emergency and the new Alert Level system required people to change their everyday lives suddenly to prevent the spread of COVID-19. New Zealanders had to physically distance; confine themselves to their homes, sometimes for weeks on end; and […]


Public Consultation Meeting on Proposed Changes to MS Treatments

December 4, 2020 | Advocacy, Life with MS, Treatments

On Friday 27th November 2020, Pharmac released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a standard Special Authority. Consultation closes 4pm […]


No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS?

November 27, 2020 | Advocacy, Life with MS, Treatments

Media Release No More Dreaded 500 Metre ‘Walk of Shame’ For Kiwis With MS? A six year battle to allow multiple sclerosis patients continued access to vital funded drug treatments may soon be over, with news that Pharmac is finally […]